Automated Cell Shakers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Automated Cell Shakers, Orbital Shakers, Benchtop Incubator Shakers, Cell Shaker with Rotatory Arms, Accessories, Others), By Application (Drug Development, Regenerative Medicine, Cell Therapy, Stem Cell Research), By End User (Pharmaceutical Companies, Biopharmaceutical Companies, CDMOs & CMOs, Hospitals, Others), By Region and Competition, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 742.81 Million
CAGR (2026-2031)	7.52%
Fastest Growing Segment	Regenerative Medicine
Largest Market	North America
Market Size (2031)	USD 1147.66 Million

Market Overview

The Global Automated Cell Shakers Market is projected to grow from USD 742.81 Million in 2025 to USD 1147.66 Million by 2031 at a 7.52% CAGR. Automated cell shakers are laboratory instruments designed to uniformly mix and agitate cell cultures, solutions, or reagents with precise control over speed and timing. This market's expansion is fundamentally driven by advancements in cell culture technology, the increasing global demand for biologics, and heightened investment in biotechnology research and development. The rising emphasis on high-throughput screening in drug discovery and the broader adoption of laboratory automation also significantly propel market growth. According to PhRMA, in 2024, the U.S. biopharmaceutical sector's R&D expenditure exceeded USD 122 billion, with a substantial portion allocated to cell-based assays and automation technologies, directly influencing the demand for automated cell shakers.

Despite these strong growth drivers, a significant impediment to market expansion remains the substantial initial capital investment required for automated systems. This financial barrier, often ranging from USD 10,000 to USD 50,000 per device, can be prohibitive for smaller academic institutions and emerging companies. Additionally, challenges associated with integrating new automated platforms into existing laboratory infrastructures further constrain wider adoption.

Key Market Drivers

Increasing demand for biopharmaceuticals and advanced therapies
Increasing demand for biopharmaceuticals and advanced therapies significantly drives the Global Automated Cell Shakers Market. The escalating prevalence of chronic diseases and the growing geriatric population underpin the need for novel therapeutic solutions, particularly in biologics and cell and gene therapies. These complex therapies necessitate precise and scalable cell culture conditions, a critical function performed by automated cell shakers to ensure consistency and accelerate development timelines. According to Fierce Biotech, in an April 2026 earnings call, Thermo Fisher Scientific’s CEO stated that demand from pharma and biotech customers was strong, with the laboratory products and biopharma services segment seeing revenues rise 7% over the same quarter last year to $6.04 billion. The expansion of biopharma pipelines and the increasing number of clinical trials for these advanced treatments directly fuel the adoption of automated cell shakers to maintain optimal cell viability and product quality throughout research and manufacturing processes.

Growing investments in life sciences research and development
Growing investments in life sciences research and development further propel market expansion. Increased funding from both private and public sectors into biotechnology and pharmaceutical R&D worldwide supports the infrastructure and equipment needed for advanced experimentation, including automated cell shakers. These investments enable laboratories to adopt high-throughput screening and other automated processes crucial for discovering and developing new drugs efficiently. According to a May 2026 article in Stock Titan, Thermo Fisher Scientific reported that its Life Sciences Solutions segment, which includes advanced lab equipment, increased revenue by 12.6% year over year in Q1 2026. This robust investment environment fosters an ecosystem where automated solutions are essential for achieving the efficiency and reproducibility required in modern life sciences research, contributing to the overall growth of the automated cell shakers market.

Download Free Sample Report

Key Market Challenges

A significant impediment to the expansion of the Global Automated Cell Shakers Market is the substantial initial capital investment required for these advanced systems. With individual devices often ranging from USD 10,000 to USD 50,000, this financial barrier presents a considerable challenge, particularly for smaller academic institutions and emerging companies operating with constrained budgets. The high upfront cost directly limits the adoption rate of automated cell shakers within segments of the market crucial for broader growth.

This financial constraint directly hampers market growth by restricting the procurement capabilities of key end-users. Academic and research institutions, fundamental drivers of scientific advancement and early technology adoption, often face budget limitations. According to the Association of American Universities (AAU), in 2025, proposed federal budget cuts for Fiscal Year 2026 indicated a $40 billion reduction from the 2025 R&D budget for federal investments. Such funding reductions severely impact the capital available for purchasing new laboratory equipment, including automated cell shakers. Additionally, the complexities associated with integrating new automated platforms into existing laboratory infrastructures further compound the challenge, requiring additional resources beyond the initial purchase price.

Key Market Trends

The integration of artificial intelligence and the Internet of Things is a transformative trend significantly impacting the Global Automated Cell Shakers Market by enabling smarter, more responsive laboratory environments. This advancement allows for real-time monitoring of shaking parameters, predictive maintenance of equipment, and dynamic adjustment of protocols to optimize cell growth and viability, minimizing human intervention and enhancing experimental reproducibility. Automated cell shakers are evolving into intelligent platforms capable of self-optimization, contributing to the broader digital transformation of life sciences research. According to Towards Healthcare, in February 2026, the AI in lab automation market currently records USD 4.19 billion, highlighting substantial investment in technologies that support such integrated systems.

Another crucial trend is the distinct shift towards closed-system and modular automated workflows, driven by the imperative for enhanced sterility, contamination control, and scalability in cell culture operations, particularly in biopharmaceutical manufacturing. This involves automated cell shakers designed to seamlessly integrate into larger, contained processing units, reducing exposure risks and ensuring product integrity throughout the culture process. The modularity allows laboratories to configure flexible setups that can be adapted to various research or production scales without extensive revalidation. According to PharmiWeb.com, in an April 2025 article, the market revenues for automated and closed cell therapy processing systems were expected to increase from USD 1.79 billion in 2025, underscoring the growing adoption of these integrated, contamination-controlled environments.

Segmental Insights

The Regenerative Medicine segment is emerging as the fastest-growing application within the Global Automated Cell Shakers Market. This rapid expansion is primarily driven by significant advancements in stem cell research and tissue engineering, which necessitate precise and controlled cell expansion environments. As regenerative therapies progress toward commercialization, there is a heightened demand for automated devices capable of providing reproducible culture conditions to support these innovative treatments. The critical need for standardized and reliable cell culture systems in developing novel therapeutic approaches further accelerates the growth of automated cell shakers in this vital medical field.

Regional Insights

North America consistently leads the Global Automated Cell Shakers Market, primarily due to its robust biotechnology and pharmaceutical sectors. The region benefits from substantial investments in research and development activities, driven by a strong focus on biologics production, cell therapies, and drug discovery programs. An advanced laboratory infrastructure, coupled with significant research spending from academic and private institutions, facilitates the widespread adoption of automated cell shakers. Additionally, supportive regulatory frameworks from bodies such as the Food and Drug Administration (FDA) foster a conducive environment for innovation and market expansion, ensuring compliance and safety in laboratory practices across the United States and Canada.

Recent Developments

• In April 2026, the Eppendorf CellXpert® CS220 CO2 Incubator Shaker was highlighted for its contributions to high-throughput cell culture applications. This unit offers an extra-large shaking platform capable of accommodating numerous flasks and can be stacked to conserve laboratory space. The CellXpert CS220 is equipped with a 180°C sterilization program and active bidirectional controls for temperature, humidity, and gas concentrations. This innovative CO2 incubator shaker advances the global market by providing enhanced contamination prevention and consistent performance for mammalian shake flask cultures.
• In December 2025, Beckman Coulter Life Sciences launched the Biomek i3 Benchtop Liquid Handler, expanding its portfolio of automated laboratory workstations. This new instrument was designed to make liquid handling research more accessible, featuring an intuitive software interface requiring no prior automation experience. The Biomek i3 supports various functions, including heating, cooling, and shaking, enabling the automation of complex protocols and improving process control without manual intervention. Its integrated shaking capability positions it as a relevant advancement within the global automated cell shakers market.
• In August 2025, Multiply Labs announced a breakthrough in cell therapy manufacturing through its collaboration with Universal Robots. They developed a robotic cluster that significantly reduced the cost of producing life-saving cell therapies. This automated system, which handles intricate tasks including the shaking of cells, aimed to transform the traditionally manual manufacturing process. The modular robotic cluster from Multiply Labs, utilizing Universal Robots' collaborative robot arms, replicates manual procedures with enhanced efficiency and sterility, directly contributing to advancements in automated cell handling within the global market.
• In March 2025, Caron Scientific, Inc. introduced the 7406 Incubator Shaker, a new product designed for high-capacity suspension cell culture within a minimal footprint. This system features an integrated design optimizing environmental uniformity across all levels. A notable innovation is its dry H₂O₂ sterilization technique, which prevents condensation and allows immediate post-cycle use, significantly enhancing contamination control and reducing technician effort. This advancement directly supports the global automated cell shakers market by offering improved efficiency and reliability for biopharmaceutical manufacturing processes.

Key Market Players

• Thermo Fisher Scientific Inc.
• Eppendorf AG
• Ohaus Corporation
• Benchmark Scientific
• Corning Incorporated
• Grant Instruments
• Kuhner Shaker
• Infors AG
• Boekel Scientific
• VELP Scientifica Srl

By Product	By Application	By End User	By Region
Automated Cell Shakers Orbital Shakers Benchtop Incubator Shakers Cell Shaker with Rotatory Arms Accessories Others	Drug Development Regenerative Medicine Cell Therapy Stem Cell Research	Pharmaceutical Companies Biopharmaceutical Companies CDMOs & CMOs Hospitals Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Automated Cell Shakers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Automated Cell Shakers Market, By Product:

• Automated Cell Shakers
• Orbital Shakers
• Benchtop Incubator Shakers
• Cell Shaker with Rotatory Arms
• Accessories
• Others

• Automated Cell Shakers Market, By Application:

• Drug Development
• Regenerative Medicine
• Cell Therapy
• Stem Cell Research

• Automated Cell Shakers Market, By End User:

• Pharmaceutical Companies
• Biopharmaceutical Companies
• CDMOs & CMOs
• Hospitals
• Others

• Automated Cell Shakers Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE